Game-Changer: Uganda to Roll Out HIV Prevention Injection in 2026
KAMPALA — A twice-yearly HIV prevention shot that has shown stunning results in clinical trials will officially arrive in Uganda in 2026, in what experts are calling a “historic turning point” in the country’s decades-long fight against the virus.
The injectable drug, Lenacapavir, developed by U.S. pharmaceutical giant Gilead Sciences, will be introduced under the President’s Emergency Plan for AIDS Relief (PEPFAR) and is expected to protect thousands of Ugandans at highest risk of infection.